FBTAX
Price
$26.51
Change
+$0.35 (+1.34%)
Updated
Jun 6 closing price
Net Assets
1.28B
LHCOX
Price
$18.52
Change
+$0.04 (+0.22%)
Updated
Jun 6 closing price
Net Assets
7.33M
Interact to see
Advertisement

FBTAX vs LHCOX

Header iconFBTAX vs LHCOX Comparison
Open Charts FBTAX vs LHCOXBanner chart's image
Fidelity Advisor Biotechnology A
Price$26.51
Change+$0.35 (+1.34%)
VolumeN/A
Net Assets1.28B
Lord Abbett Health Care F3
Price$18.52
Change+$0.04 (+0.22%)
VolumeN/A
Net Assets7.33M
FBTAX vs LHCOX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FBTAX vs. LHCOX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FBTAX is a Buy and LHCOX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FBTAX has more cash in the bank: 1.28B vs. LHCOX (7.33M). FBTAX pays higher dividends than LHCOX: FBTAX (3.05) vs LHCOX (0.61). FBTAX was incepted earlier than LHCOX: FBTAX (24 years) vs LHCOX (6 years). LHCOX (2.99) is less costly to investors than FBTAX (0.96). LHCOX is a more actively managed with annual turnover of: 88.00 vs. FBTAX (73.00). FBTAX (0) and LHCOX (0) have matching initial minimum investment requirements. LHCOX annual gain was more profitable for investors over the last year : -5.26 vs. FBTAX (-7.86). LHCOX return over 5 years is better than : 7.64 vs. FBTAX (-11.02).
FBTAXLHCOXFBTAX / LHCOX
Total Expense Ratio0.960.68141%
Annual Report Gross Expense Ratio0.962.9932%
Fund Existence24 years6 years-
Gain YTD-3.859-4.84080%
Front Load6%N/A-
Min. Initial Investment00-
Min. Initial Investment IRAN/AN/A-
Net Assets1.28B7.33M17,398%
Annual Yield % from dividends3.050.61502%
Returns for 1 year-7.86-5.26149%
Returns for 3 years30.219.74310%
Returns for 5 years-11.027.64-144%
Returns for 10 years-6.12N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JDNRX71.38N/A
N/A
Janus Henderson Growth And Income R
PGRUX9.56N/A
N/A
Principal Global Real Estate Sec R5
TEMUX14.87N/A
N/A
Morgan Stanley Pathway Em Mkts Eq
SCIUX11.18N/A
N/A
Invesco Income Advantage U.S. Fund R5
GEBRX10.73N/A
N/A
Goldman Sachs ESG Em Mkts Eq R